Jeffrey Segal MD, JD, a medico-legal expert and the founder of Medical Justice, discussed the shifting dynamics of the market for GLP-1 receptor agonist medications in a recent blog, “The Whirlwind ...
On June 7, 2002, the FDA issued a compliance policy guidance to FDA staff and the drug compounding industry to explain how it will regulate pharmacy compounding in the immediate future in light of ...